Express Healthcare
Home  »  News  »  USAID supported Samridh Healthcare to accelerate COVID response in India

USAID supported Samridh Healthcare to accelerate COVID response in India

0 186
Read Article

SAMRIDH Healthcare Blended Financing Facility combines public and philanthropic funds with commercial capital to fund healthcare businesses with innovative market-based solutions

In order to accelerate India’s COVID response, the United States Agency for International Development (USAID)-supported SAMRIDH Healthcare Blended Financing Facility has committed $27 million to support India’s national health priorities, including oxygen delivery systems, cold chain storage for vaccines, supply chain management for COVID-19 medicines, training for healthcare workers, and other hospital and community-based activities.

Commenting on the same, Karen Klimowski, USAID/India Acting Mission Director said, “USAID’s support to SAMRIDH reflects the United States’ strong commitment to accelerating India’s response to the COVID-19 pandemic. Through SAMRIDH, USAID is identifying and fast-tracking the deployment of solutions to some of the most pressing healthcare challenges posed by the pandemic including the shortage of medical oxygen and lack of adequate vaccine storage facilities.”

Implemented by IPE Global, SAMRIDH Healthcare works in technical collaboration with institutions like Indian Institute of Technology/Delhi, the Principal Scientific Advisor to the Government of India, the National Health Authority, and NATHEALTH.

Ashwajit Singh, Managing Director, IPE Global said, “At a time when India’s healthcare systems are in urgent need of reinforcement, USAID’s additional support to SAMRIDH will help it to scale-up and deploy lifesaving health solutions. Through our continuing engagement with USAID, we support resilient and inclusive health systems, ensuring everyone has access to timely, affordable, and quality healthcare services.”

SAMRIDH Healthcare Blended Financing Facility combines public and philanthropic funds with commercial capital to fund healthcare businesses with innovative market-based solutions that can meet the challenges posed by the pandemic.

 

 

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
close-image